Can sequencing immunotherapy before chemo boost stomach cancer outcomes?
Disease control
Ongoing
This phase 2 trial is testing whether giving the immunotherapy drug pembrolizumab first, followed by a combination of ramucirumab and paclitaxel, can shrink tumors and delay progression in people with advanced gastric or gastroesophageal junction adenocarcinoma. The study enrolls…
Phase: PHASE2 • Sponsor: Harry H Yoon • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC